nivolumab,ipilimumab,cabozantinib
bms,exelixis
['nivo', 'triplet,(-triplete)', '/ipi', 'rcc,(-irccs),(-srcc),(-urcc)', 'cosmic-313']
a comprehensive and well balanced discussion by of the cosmic-313 study: the first trial of triplet vs nivo/ipi doublet in #rcc primary endpoint of pfs met, but questions re toxicity and lack of os data remain. #esmo2022 
Assistant Professor @UCSF @ucsfcancer in GU Oncology. Alum of @ClevelandClinic @umichmedicine @UChiPritzker @Penn Tweet re GU oncology